• Study reports abnormally high VTE and high bleed risk in critically ill Covid-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of Covid-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Learn more Contact us

OnPulse Technology

The revolutionary neuromuscular electrostimulation technology developed by Firstkind

Find out more

geko™ product

Hospital Applications Device

Find out more

Partner with us

What can the geko™ do for my patients?


Health tech adoption is tough.  It should be tough, but we aim to make it a little easier


Firstkind reaccredited by RCN for geko™ user training programme in VTE prevention

Social Media

Follow our social media channels to read our latest updates

Social Media